The Petri Dish: Sarepta hit with clinical hold, Decibel stock soars


The FDA has placed a clinical hold on a Duchenne muscular dystrophy drug made by Sarepta Therapeutics Inc.

Previous Exclusive: DFW fintech Meritize closes investment to scale student lending platform
Next St. Louis Character: Christine Hyman, mother of transgender son, hopes to change hearts and minds